
| ID | 70780 |
| フルテキストURL | |
| 著者 |
Morii, Mariko
Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University
Kubota, Sho
Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Sashida, Goro
Laboratory of Transcriptional Regulation in Leukemogenesis, International Research Center for Medical Sciences, Kumamoto University
|
| 抄録 | TIF1β/TRIM28/KAP1 has been recognized as a scaffold protein that partners with KRAB-ZFPs and heterochromatin complexes to enforce gene silencing. In embryonic and pluripotent stem cells, it maintains self-renewal by silencing endogenous retroelements through the establishment of heterochromatin. While these canonical functions have been extensively examined in embryonic stem (ES) cells, accumulating evidence also highlights its diverse contributions to cancer biology. We herein focused on the oncogenic role of TIF1β in leukemic progression, contrasting this with its physiological roles in hematopoietic stem cell maintenance, differentiation, and immune regulation, thereby providing a comparative perspective on H3K9 methyltransferase SETDB1-dependent and -independent mechanisms. TIF1β-mediated epigenetic plasticity was recently shown to establish a leukemic chromatin environment for promoting oncogenic transcriptional programs while repressing lineage-differentiation regulators, which drives leukemic progression in a context-dependent manner. This review summarizes the dual role of TIF1β as a chromatin modulator, functioning both as a canonical transcriptional co-repressor and as a context-dependent co-activator, and also discusses how these modalities cooperate to sustain leukemic stem cell programs.
|
| キーワード | BCR::ABL1
hematopoiesis
heterochromatin
leukemia
transcription
|
| 発行日 | 2026-01-27
|
| 出版物タイトル |
Cancer Science
|
| 巻 | 117巻
|
| 号 | 4号
|
| 出版者 | Wiley
|
| 開始ページ | 896
|
| 終了ページ | 903
|
| ISSN | 1347-9032
|
| NCID | AA11808050
|
| 資料タイプ |
学術雑誌論文
|
| 言語 |
英語
|
| OAI-PMH Set |
岡山大学
|
| 著作権者 | © 2026 The Author(s).
|
| 論文のバージョン | publisher
|
| PubMed ID | |
| DOI | |
| Web of Science KeyUT | |
| 関連URL | isVersionOf https://doi.org/10.1111/cas.70334
|
| ライセンス | http://creativecommons.org/licenses/by-nc/4.0/
|
| Citation | M. Morii, S. Kubota, and G. Sashida, “Roles of TIF1β in Leukemic Stem Cell Through SETDB1-Dependent and Independent Mechanisms,” Cancer Science117, no. 4 (2026): 896–903, https://doi.org/10.1111/cas.70334.
|
| 助成情報 |
( 公益財団法人安田記念医学財団 / Yasuda Medical Foundation )
( 公益財団法人先進医薬研究振興財団 / SENSHIN Medical Research Foundation )
15K19545:
造血器腫瘍におけるKAP1チロシンリン酸化の機能解析
( 独立行政法人日本学術振興会 / Japan Society for the Promotion of Science )
20K17383:
転写制御因子TIF1βによる白血病幹細胞制御機構の解明と治療標的検証
( 独立行政法人日本学術振興会 / Japan Society for the Promotion of Science )
21H02952:
ストレス造血における幹細胞エピゲノム制御と細胞運命決定機構の解析
( 独立行政法人日本学術振興会 / Japan Society for the Promotion of Science )
( 公益財団法人小林がん学術振興会 / Kobayashi Foundation for Cancer Research )
( 特定非営利活動法人白血病研究基金を育てる会 / Friends of Leukemia Research Fund )
|